Induction of cell death by combination treatment with cisplatin and 5-fluorouracil in a human oral squamous cell carcinoma cell line

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3331-3337

  Okamura, Masahiko ^a   Kobayashi, Masaki ^a   Suzuki, Fumika ^a   Shimada, Jun ^a   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

5 fluorouracil; Chemotherapy; Cisplatin; Combination effect; Cytotoxicity; HSC 2; Oral squamous cell carcinoma; Polyamine

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CISPLATIN; DACTINOMYCIN; DNA FRAGMENT; FLUOROURACIL; PUTRESCINE;

ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BIOGENIC POLYAMINES; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; CISPLATIN; DNA FRAGMENTATION; DRUG ADMINISTRATION SCHEDULE; ENZYME ACTIVATION; FLUOROURACIL; HL-60 CELLS; HUMANS; ISOENZYMES; MOUTH NEOPLASMS;

EID: 35348989212     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kohno N, Kitahara S, Tamura E, Tanabe T, Nakanoboh M, Kawada M and Shirasaka T: The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck. Gan To Kagaku Ryoho 27(suppl 2): 592-599, 2000 (In Japanese).
2. Andreadis C, Vahtsevanos K, Sidiras T, Thomaidis I, Antoniadis K and Mouratidou D: 5-Fluorouracil and cisplatin in the treatment of advanced oral cancer. Oral Oncol 39: 380-385, 2003.
3. Mercier RJ, Neal GD, Mattox DE, Gates GA, Pomeroy TC and Von Hoff DD: Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of head and neck. Cancer 60: 2609-2612, 1987.
4. Thyss A, Schneider M, Santini J, Caldani C, Vallicioni J, Chauvel P and Demard F: Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer 54: 755-760, 1986.
5. Amrein PC and Weitzman SA: Treatment of squamous cell carcinoma of head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 3: 1632-1639, 1985.
6. Kish JA, Ensley JF, Jacobs J, Weaver A, Cummings G and AI-Sarraf M: A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56: 2740-2744, 1985.
7. Kish JA, Weaver A, Jacobs J, Cummings G and AI-Sarraf M: Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1819-1824, 1984.
8. Kin R and Togo T: Induction of apoptosis by treatment with low-dose cisplatin and 5-fluorouracil. Hematol Oncol 44: 154-159, 2002 (in Japanese).
9. Lee J, Lee KE, Im YH, Kang WK, Park K, Kim K and Shim YM: Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 80: 1170-1175, 2005.
10. Braly PS, Berek JS, Blessing JA, Homesley HD and Averette H: Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group. Gynecol Oncol 56: 164-168, 1995.
11. Itoh Y, Fuwa N, Matsumoto A, Asano A and Morita K: Continuous infusion low-dose CDDP/5-FU plus radiation in inoperable or recurrent non-small-cell lung cancer: preliminary. Am J Clin Oncol 25: 230-234, 2002.
12. Azuma M, Harada K, Supriatno, Tamatani T, Motegi K, Ashida Y and Sato M: Potentiation of induction of apoptosis by sequential treatment with cisplatin followed by 5-fluorouracil in human oral cancer cells. Int J Oncol 24: 1449-1455, 2004.
13. Etienne MC, Bernard S, Fischel JL, Formento P, Gioanni J, Santini J, Demard F, Schneider M and Milano G: Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines. Br J Cancer 63: 372-377, 1991.
14. Seiler N and Raul F: Polyamines and apoptosis. J Cell Mol Med 19: 623-642, 2005.
15. Nakamura C, Yasumoto E, Nakano K, Nakayachi T, Hashimoto K, Kusama K, Fukuda M, Sakashita H, Shirahata A and Sakagami H: Changes in intracellular concentrations of polyamines during apoptosis of HL-60 cells. Anticancer Res 23: 4797-4804, 2003.
16. Sakagami H, Fujiwara E, Yokote Y, Akahane K, Asano K, Kochi M, Hara E and Shirahata A: Changes in intracellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells. Anticancer Res 20: 265-270, 2000.
17. Okamura M, Hashimoto K, Shimada J and Sakagami H: Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines. Anticancer Res 24: 655-662, 2004.
18. Seiler N: Use of the dansyl reaction in biochemical analysis. Methods Biochem Anal 18: 259-337, 1970.
19. Hashimoto T, Omura K, Sunohara T, Osari A, Yasuda T, Kawakami K, Matsu T, Ishida F, Watanabe Y, Fukushima M, and Shirasaka T: Pharmacokinetics and changes of reduced folate levels in tumor after administration of cisplatin. Gan To Kagaku Ryoho 21: 859-864, 1994 (In Japanese).
20. Pratesi G, Gianni L, Manzoti C and Zunino F: Sequence dependence of the antitumor and toxic effects of 5-fluorouracil and cis-diamminedichloroplatinum combination on primary colon tumors in mice. Cancer Chemother Pharmacol 21: 237-240, 1988.
21. Araki H, Fukushima M, Kamiyama Y and Shirasaka T: Effect of consecutive low-dose cisplatin in enhancement of 5-fluorouracil cytotoxicity in experimental tumor cells in vivo. Cancer Lett 160: 185-191, 2000.
22. Broker LE, Kruyt FAE and Giaccone G: Cell death independent of caspase: A review. Clin Cancer Res 11: 3155-3162, 2005.
23. Daido S, Yamamoto A, Fujisawa K, Sawaya R, Kondo S and Kondo Y: Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 65: 4368-4375, 2005.
24. Daido S, Kanazawa T, Yamamoto A, Takeuchi H, Kondo Y and Kondo S: Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64: 4286-93, 2004.
25. Takeuchi R, Hoshijima H, Onuki N, Nagasaka H, Chowdhury SA, Kawase M and Sakagami H: Effect of anticancer agents on codeinone-induced apoptosis in human cancer cell lines. Anticancer Res 25: 4037-4042, 2005.
26. Takeuchi R, Hoshijima H, Nagasaka H, Chowdhury SA, Kikuchi H, Kanda Y, Kunii S, Kawase M and Sakagami H: Induction of non-apoptotic cell death by morphinone in human promyelocytic leukemia HL-60 cells. Anticancer Res 26: 3343-3348, 2006.
27. Nakayachi T, Yasumoto E, Nakano K, Morshed SRM, Hashimoto K, Kikuchi H, Nishikawa H, Kawase M and Sakagami H: Structure-activity relationships of α,β-unsaturated ketones as assessed by their cytotoxicity against oral tumor cells. Anticancer Res 24: 737-742, 2004.
28. Ideo A, Sasaki M, Nakamura C, Mori K, Shimada J, Kanda Y, Kunii S, Kawase M and Sakagami H: Cytotoxic activity of selected trifluoromethylketones against oral tumor cells. Anticancer Res 26: 4335-4342, 2006.
29. Zhang W, Ramdas L, Shen W, Song SW, Hu L and Hamilton SR: Apoptotic response to 5-fluorouracil treatment is mediated by reduced polyamines, non-autocrine Fas ligand and induced tumor necrosis factor receptor 2. Cancer Biol Ther 2: 572-578, 2003.
30. Stachurska A, Dudkowska M, Czopek A, Manteuffel-Cymborowska M and Grzelakowska-Sztabert B: Cisplatin upregulates the in vivo biosynthesis and degradation of renal polyamines and c-Myc expression. Biochim Biophys Acta 1689: 259-266, 2004.
31. Calabrese EJ: Paradigm lost, paradigm found: The reemergence of hormesis as a fundamental dose-response model in the toxicological sciences. Env Poll 138: 379-412, 2005.
32. Brune B, Hartzell P, Nicotera P and Orrenius S: Spermine prevents endonuclease activation and apoptosis in thymocytes. Exp Cell Res 195: 323-329, 1991.
33. Derka S, Vairaktaris E, Papakosta V, Vassiliou S, Acil Y, Vylliotis A, Spyridonidou S, Lazaris AC, Mourouzis C, Kokkori A, Moulavasilli P, Perrea D, Donta I, Yapijakis C and Patsouris E: Cell proliferation and apoptosis culminate in early stage of oral oncogenesis. Oral Oncol 42: 540-550, 2006.